Drug Screening at ALS TDI
Modeling ALS for Drug Screening at ALS TDI
In-vivo (in animal) drug testing is an important step in demonstrating if a drug appears promising enough – and safe enough – to move into a clinical trial in humans.
Dr. Theo Hatzipetros, ALS TDI’s Director of Pharmacology, explains how in-vivo testing works, how in-vivo models are developed and validated, and what new models ALS TDI is currently working on.
Read more here